Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-24-001748
Filing Date
2024-11-18
Accepted
2024-11-18 17:20:53
Documents
77
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gevi_10q.htm   iXBRL 10-Q 1427081
2 CERTIFICATION gevi_ex311.htm EX-31.1 10845
3 CERTIFICATION gevi_ex321.htm EX-32.1 4917
  Complete submission text file 0001640334-24-001748.txt   7041092

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gevi-20240930.xsd EX-101.SCH 77335
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gevi-20240930_lab.xml EX-101.LAB 342493
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gevi-20240930_cal.xml EX-101.CAL 50791
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gevi-20240930_pre.xml EX-101.PRE 304140
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gevi-20240930_def.xml EX-101.DEF 192220
80 EXTRACTED XBRL INSTANCE DOCUMENT gevi_10q_htm.xml XML 1477513
Mailing Address 1740H DEL RANGE BLVD SUITE 166 CHEYENNE WY 82009
Business Address 1740H DEL RANGE BLVD SUITE 166 CHEYENNE WY 82009 800-401-4535
General Enterprise Ventures, Inc. (Filer) CIK: 0000894556 (see all company filings)

EIN.: 872765150 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56567 | Film No.: 241472488
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)